Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund · Equity · mandate: ≥80% in the named sector/theme · benchmark: —
AUM (all plans)
1,322 cr
CAGR (full)
18.2%
Sharpe (full)
0.78
Sharpe (bull ≤Sep-24)
2.98
Sharpe (sideways Oct-24→)
0.04
Max drawdown
-18.3%
Months of data
128
Percentile ranks this fund within its peer pool; the leaderboard Score is
the weighted average of its fiscal-year percentiles (equity: active-return-rank blended
with IR-rank).
Equity curve
Drawdown
Fiscal-year record
FY
Return
vs category
Sharpe
months
FY22
18.4%
-2.6%
0.81
12
FY23
-6.1%
-9.4%
-1.02
12
FY24
60.1%
13.8%
2.97
12
FY25
16.0%
8.9%
0.53
12
FY26
-0.4%
0.8%
-0.45
12
FY27*
20.3%
1.9%
4.44
5
Active/Fund returns are TOTALS over the months covered — never annualized
(FY27* is year-to-date; a * row covers only part of the year).
%ile is the fund's percentile within its peer pool for that year.
Monthly returns (%)
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Year
2016
+0.9
-5.4
-1.6
+1.6
-3.0
+1.6
+7.2
-4.4
-0.1
-0.2
-2.3
-7.4
-13.1
2017
+0.7
+4.9
+1.2
+1.3
-8.4
+3.3
+0.5
-7.9
+1.9
+5.9
+0.4
+3.5
+6.4
2018
+0.3
-2.8
-4.0
+7.3
-9.4
+5.8
+3.2
+10.8
-6.2
-1.6
-1.2
-1.3
-0.8
2019
+0.2
-1.5
+6.0
+1.6
-5.1
-0.8
+1.6
+0.1
+0.5
+3.4
+2.6
-1.3
+7.2
2020
+4.6
+0.2
-7.0
+21.6
+2.6
+0.6
+11.7
+1.0
+8.3
-1.4
+5.5
+7.3
+66.9
2021
-4.1
-0.9
+2.8
+8.9
+3.6
+4.0
+3.2
+3.1
-2.1
-4.0
+2.6
+2.9
+20.9
2022
-6.1
-2.9
+5.0
-1.9
-5.6
-2.8
+6.1
-0.2
+2.5
+2.8
+0.5
-3.4
-6.6
2023
-1.6
-3.7
+1.5
+4.0
+2.8
+8.1
+8.4
+0.4
+2.5
-3.6
+11.8
+3.8
+38.6
2024
+6.2
+4.6
+0.1
+0.6
-0.5
+4.9
+10.4
+7.1
+0.9
-1.3
-0.6
+4.4
+42.5
2025
-7.6
-9.3
+8.0
+2.6
-0.2
+3.4
+3.5
-2.5
-1.2
+2.5
+0.7
-2.1
-3.5
2026
-5.4
+5.3
-6.3
+7.0
+4.1
+3.7
+4.4
-0.2
+12.3
Quarterly average AUM & estimated net flows
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by
construction). Monthly returns are month-end NAV chains; stale prints (>7 days before
month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla
direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified
against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic
monthly convention. Independence: all figures are computed from mandatory public disclosures with a
fixed methodology applied identically to every fund — no fund can pay for inclusion,
exclusion, placement, or altered presentation, and any material commercial relationship
will be disclosed on the affected pages.
Nothing here is investment advice; past performance does not
predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard
· PMS leaderboard